The BCCNM board on Nov. 18, 2026, approved the new practice standard Nurse Practitioners: Prescribing and Ordering Drugs and Substances. The standard comes into effect on Jan. 30, 2027.
The new standard brings NP prescribing and ordering requirements together in one place, making them clearer, more current, and easier to use. It consolidates and replaces the Nurse Practitioners: Prescribing Drugs and Nurse Practitioners: Prescribing for Opioid Use Disorder and/or Prescribed Alternatives standards and relocates relevant prescribing content from the Nurse Practitioners: Advanced Procedures and Activities standard.
What's changing
- Updates to improve clarity, align with legislative changes, and reflect current NP practice.
- Prescribing and ordering requirements, including existing requirements for opioid use disorder and prescribed alternatives, are now in a single standard.
- The standard distinguishes between prescribing a drug for a pharmacist to dispense and ordering a drug or substance for another regulated health professional to administer.
- Named courses and competencies for controlled drugs and substances prescribing are no longer specified in the standard.
What's not changing
- Consolidation does not broadly expand or restrict NP scope of practice.
- NPs remain accountable for practising within their scope, competence, applicable legislation, BCCNM standards, and organizational policies.
- NPs must ensure they have the competence to provide safe, competent care for their setting and patient population, and seek education or training where gaps are identified. Development goals can be included in your quality assurance requirements.
Questions?
Connect with our Standards Support team.